-cells was not significantly different between women with IVF failure and successful IVF (p=0.28).
Introduction
nfertility is an increasing medical and social problem. It is estimated that in developed countries 15% of the couples are infertile (1) . In vitro fertilization (IVF) which is a high complex technique has become a common and accessible treatment for a wide variety of indications (2) . For IVF cycles, the success rate is 40.1% in women less than 35 years to 20.6% in women in the 41-42 years range (3) . However, in spite of significant advances, IVF cycle success rates are universally <50% and often <25%. Lost pregnancies are usually due to implantation failure (50-75%) (4) .
Although suggestions have included the failure of at least three cycles of IVF or two cycles of IVF, for repeated IVF failure, there is still no formal consensus definition. Therefore, recently, managing couples with repeated IVF failure and improve IVF outcomes is the urgent need (5) . An immunologic basis for unexplained failures has been suspected for many years. The role of the immune system has been confirmed in embryo implantation process (6 
Materials and methods
This cross sectional study was done from July to December 2013 in Al-Zahra Hospital, Isfahan, Iran. This study was included 50 infertile women who had an indication for IVF treatment. This study was approved by Isfahan University of Medical Sciences. Written informed consent was obtained from all of participants. Advanced maternal age (≥35 years old), history of recurrent miscarriage (due to PCOS, congenital uterine abnormality, thyroid dysfunction, diabetes mellitus or a positive thrombophilia screen), male factor infertility and endometriosis were excluded from the study. Endometrial thickness <8 mm before embryo transfer or fewer than two embryos available for transfer, immune therapy, and taking corticosteroids were the other exclusion criteria.
Collected information were included; age, body mass index (BMI), parity, previous IVF failures, duration of infertility, and the level of The peripheral blood cells were washed twice with phosphate-buffered saline before staining, then using color fluorescenceactivated cell sorting scan, NK cells were determined after staining with monoclonal antibodies (PARTEC Germany) to CD16 and CD56. To assess IVF outcome pregnancy test was taken from some women had menstruation and had missed period. Successful IVF defined by positive blood bhuman chorionic gonadotropin tests performed in the two week after embryo transfer.
Statistical analysis
The sample size was calculated to compare two proportions, with two-sided logrank test, α=0.05, and 80% power. bright CD16 -cells was not normal in studied subjects. The Student's t-test and Mann-Whitney U-test were used to compare data between women with successful IVF and women with failure IVF. For All probability used tests alpha was set at 5%.
Results
The mean age of our participants was 32.61±1.70 years. In total, 16 successful IVF cycles (32%) and 34 IVF failure (68%) were observed.
The study population characteristics in regard to both successful IVF and IVF failure are shown in table I. Women with successful IVF were significantly younger than women with IVF failure (p=0.003). The mean of BMI in women with successful IVF was less than other women, but this difference was not statistically significant (p=0.36).
Previous IVF failures and duration of infertility in women with successful IVF and IVF failure had not statistically significant difference (p=0.12, p=0.61, respectively). The level of CD56 dim CD16+ cells in successful IVF group was 4.51±0.98 whereas in IVF failure group it was 13.62±4.63. As it is shown in figure 1, 
Discussion
The results of the present study showed that 68% of treated women did not respond to IVF therapy and 32% had successful IVF. 
